Accueil
Détail de l'auteur
Auteur H. E. JONES |
Documents disponibles écrits par cet auteur (24)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Périodique
M. TUTEN ; H. E. JONES ; G. TRAN ; D. S. SVIKIS | 2004The present study compared pregnant, drug-dependent women reporting current partner abuse (n = 26) or no partner abuse (n = 76) at treatment enrollment on initial psychosocial and psychiatric functioning. Abused pregnant women presented with mor[...]Périodique
H. E. JONES ; D. S. SVIKIS ; G. TRAN | 2002ENGLISH : Treatment compliance is an important variable in drug use intervention. For pregnant drug-misusing women, compliance with treatment has been particularly problematic, even in specialized and more intensive treatment programs. The pre[...]Article : Périodique
Buprenorphine is a new and attractive medication option for many opioid-addicted adults and their physicians. Before initiating buprenorphine treatment, providers must be aware of such critical factors as how the medication works, its efficacy a[...]Périodique
H. E. JONES | 2004Buprenorphine is a new and attractive medication option for many opioid-addicted adults and their physicians. Before initiating buprenorphine treatment, providers must be aware of such critical factors as how the medication works, its efficacy a[...]Article : Périodique
H. E. JONES ; N. J. WELTON ; A. E. ADES ; M. PIERCE ; W. DAVIES ; B. COLEMAN ; T. MILLAR ; M. HICKMAN |Background and Aims: Capture-recapture (CRC) analysis is recommended for estimating the prevalence of problem drug use or people who inject drugs (PWID). We aim to demonstrate how naive application of CRC can lead to highly misleading results, a[...]Périodique
H. E. JONES ; R. E. JOHNSON ; D. R. JASINSKI ; L. MILIO | 2005ENGLISH : This study compared the safety and withdrawal discomfort associated with transitioning pregnant opioid-dependent women from short-acting morphine onto buprenorphine or methadone under well-controlled double-blind conditions. Particip[...]Périodique
H. E. JONES ; R. E. JOHNSON ; G. E. BIGELOW ; K. SILVERMAN ; MUDRIC T. ; E. C. STRAIN | 2004ENGLISH : L-tryptophan(ie, tryptophan) has shown promise as a pharmacotherapy in cocaine addiction treatment. Abstinent contingent voucher incentives have shown efficacy in abstinence initiation and maintenance for treatment of cocaine depende[...]Périodique
H. E. JONES ; N. A. HAUG ; K. SILVERMAN ; M. STITZER ; D. SVIKIS | 2001FRANÇAIS : Les bénéfices d'un traitement contingent, associé à des avantages progressifs (argent ou biens de consommations) sont évalués chez des femmes enceintes toxicomanes, dépendantes d'opiacés sous méthadone et consommatrices de cocaïne. [...]Article : Périodique
ENGLISH : It is estimated that 55-94% of infants born to opioid-dependent mothers in US will show signs of opioid withdrawal. Buprenorphine has been reported to produce little or no autonomic signs or symptoms of opioid withdrawal following ab[...]Périodique
H. E. JONES ; D. SVIKIS ; ROSADO J. ; M. TUTEN ; KULSTAD J. L. | 2004ENGLISH : Despite specialized drug treatment, many pregnant drug-using women do not seek admission to such programs. This study examined two types of brief drug use intervention models for attracting and retaining pregnant women in drug abuse [...]